MiMedx Group (MDXG) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street gains as healthcare stocks rally, oil prices fall
- Brent slips in choppy session as investors weigh attacks on ships, Saudi infrastructure
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
Tweet
Share
E-mail
Get Alerts MDXG Hot Sheet
Join SI Premium – FREE
MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $87.21 million versus the consensus estimate of $89.09 million.
For earnings history and earnings-related data on MiMedx Group (MDXG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US Seeks More Competition In Kidney Treatment Market - Axios
- Iran-US Talks Continue, Reports Deal Is Close Are Wrong: Person - Bloomberg
- Rapport Therapeutics (RAPP) PT Raised to $86 at Raymond James
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
